A Boggild1, J Brophy2, P Charlebois3, M Crockett4, J Geduld5, W Ghesquiere6, P McDonald7, P Plourde8, P Teitelbaum9, M Tepper10, S Schofield11, A McCarthy12. 1. University Health Network, Toronto General Hospital (Toronto, ON). 2. Division of Infectious Diseases, Children's Hospital of Eastern Ontario (Ottawa, ON). 3. Internal Medicine, Canadian Forces Health Services Centre (Atlantic) (Halifax, NS). 4. Paediatrics and Child Health, University of Manitoba (Winnipeg, MB). 5. Infectious Disease Prevention and Control Branch, Public Health Agency of Canada (Ottawa, ON). 6. Infectious Diseases and Internal Medicine, University of British Columbia (Victoria, BC). 7. Therapeutic Products Directorate, Health Canada (Ottawa, ON). 8. Faculty of Medicine, University of Manitoba (Winnipeg, MB). 9. Riverside Travel Medicine Clinic (Ottawa, ON). 10. Communicable Disease Control Program, Directorate of Forces Health Protection (Ottawa, ON). 11. Pest Management Entomology, Directorate of Forces Health Protection (Ottawa, ON). 12. Tropical Medicine and International Health Clinic, Division of Infectious Disease, Ottawa Hospital General Campus (Ottawa, ON).
Abstract
BACKGROUND: On behalf of the Public Health Agency of Canada, the Committee to Advise on Tropical Medicine and Travel (CATMAT) developed the Canadian Recommendations for the Prevention and Treatment of Malaria Among International Travellers for Canadian health care providers who are preparing patients for travel to malaria-endemic areas and treating travellers who have returned ill. OBJECTIVE: To provide guidelines on risk assessment and prevention of malaria. METHODS: CATMAT reviewed all major sources of information on malaria prevention, as well as recent research and national and international epidemiological data, to tailor guidelines to the Canadian context. The evidence-based medicine recommendations were developed with associated rating scales for the strength and quality of the evidence. RECOMMENDATIONS: Used together and correctly, personal protective measures (PPM) and chemoprophylaxis very effectively protect against malaria infection. PPM include protecting accommodation areas from mosquitoes, wearing appropriate clothing, using bed nets pre-treated with insecticide and applying topical insect repellant (containing 20%-30% DEET or 20% icaridin) to exposed skin. Selecting the most appropriate chemoprophylaxis involves assessment of the traveller's itinerary to establish his/her malaria risk profile as well as potential drug resistance issues. Antimalarials available on prescription in Canada include chloroquine (or hydroxychloroquine), atovaquone-proguanil, doxycycline, mefloquine and primaquine.
BACKGROUND: On behalf of the Public Health Agency of Canada, the Committee to Advise on Tropical Medicine and Travel (CATMAT) developed the Canadian Recommendations for the Prevention and Treatment of Malaria Among International Travellers for Canadian health care providers who are preparing patients for travel to malaria-endemic areas and treating travellers who have returned ill. OBJECTIVE: To provide guidelines on risk assessment and prevention of malaria. METHODS: CATMAT reviewed all major sources of information on malaria prevention, as well as recent research and national and international epidemiological data, to tailor guidelines to the Canadian context. The evidence-based medicine recommendations were developed with associated rating scales for the strength and quality of the evidence. RECOMMENDATIONS: Used together and correctly, personal protective measures (PPM) and chemoprophylaxis very effectively protect against malaria infection. PPM include protecting accommodation areas from mosquitoes, wearing appropriate clothing, using bed nets pre-treated with insecticide and applying topical insect repellant (containing 20%-30% DEET or 20% icaridin) to exposed skin. Selecting the most appropriate chemoprophylaxis involves assessment of the traveller's itinerary to establish his/her malaria risk profile as well as potential drug resistance issues. Antimalarials available on prescription in Canada include chloroquine (or hydroxychloroquine), atovaquone-proguanil, doxycycline, mefloquine and primaquine.
Authors: A Boggild; J Brophy; P Charlebois; M Crockett; J Geduld; W Ghesquiere; P McDonald; P Plourde; P Teitelbaum; M Tepper; S Schofield; A McCarthy Journal: Can Commun Dis Rep Date: 2014-05-15
Authors: A Boggild; J Brophy; P Charlebois; M Crockett; J Geduld; W Ghesquiere; P McDonald; P Plourde; P Teitelbaum; M Tepper; S Schofield; A McCarthy Journal: Can Commun Dis Rep Date: 2014-04-03